Blog
RSS FeedPosted by Michael Wonder on 05 Oct 2021
The Product Monograph for Protopic has been updated
4 October 2021 - LEO Pharma Inc. today announced that Health Canada has approved an update to the Product Monograph of ...
Posted by Michael Wonder on 03 May 2021
Statement from Health Canada on Janssen COVID-19 vaccines and Emergent BioSolutions
30 April 2021 - Health Canada continues to ensure the quality and safety of vaccines coming into Canada by working ...
Posted by Michael Wonder on 30 Mar 2021
Health Canada taking further action to confirm the benefit-risk profile of the AstraZeneca vaccine
29 March 2021 - As part of Health Canada’s continuing commitment to openness and transparency on all information relating to ...
Posted by Michael Wonder on 30 Mar 2021
Canada urges halt in use of AstraZeneca COVID-19 vaccine in people under 55
30 March 2021 - Canadian authorities recommended Monday a halt on administering the AstraZeneca PLC COVID-19 vaccine on people under ...
Posted by Michael Wonder on 24 Mar 2021
Health Canada says AstraZeneca shot is safe as U.S. questions vaccine's clinical trial data
23 March 2021 - U.S. regulator says AstraZeneca may have included 'outdated' data when releasing clinical trial results. ...
Posted by Michael Wonder on 28 Oct 2020
Leo Pharma is withdrawing the drug Picato (ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
27 October 2020 - At Health Canada's request, Leo Pharma is withdrawing Picato from the Canadian market. ...
Posted by Michael Wonder on 01 Oct 2020
Fibristal (ulipristal acetate 5 mg tablets) voluntary withdrawal in Canada due to risk of drug-induced liver injury
30 September 2020 - Allergan is working closely with Health Canada to voluntarily withdraw Fibristal (ulipristal acetate 5 mg tablets) ...
Posted by Michael Wonder on 27 Apr 2020
Health Canada issues warning against use of hydroxychloroquine for COVID-19
26 April 2020 - Health Canada is warning the public of the possible side effects of a drug that U.S. ...
Posted by Michael Wonder on 23 May 2019
B.C. eye doctors warn province of spike in glaucoma cases linked to injections of eye drug
23 May 2019 - Thousands of retinal-disease patients in British Columbia are being exposed to an “increased risk of severe ...
Posted by Michael Wonder on 15 Jan 2019
Health Canada restricts Allergan's Esmya
15 January 2019 - Health Canada has placed restrictions on Allergan's uterine fibroid treatment Esmya, after discovering a possible link ...
Posted by Michael Wonder on 12 Nov 2018
Oversight gap at private infusion clinics poses health risk, Ontario documents say
12 November 2018 - The lack of formal oversight at private clinics where medications are administered intravenously could pose risks ...